The most common question is about what type of MS do I have. So we'll go online, and I'll see this relapsing, remitting, and primary progressive and secondary progression. All of those names were ...

Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...

Most people living with MS will undergo a certain amount of disease progression. To help determine your personal outlook, it helps to understand the risk factors that may indicate a greater chance ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The observation that progression can occur without preceding ...

today showed that tolebrutinib was able to delay the time to six-month disability progression by 31% compared to placebo in patients with non-relapsing secondary progressive multiple sclerosis ...

have shown that the commonly used high-cholesterol drug simvastatin cannot slow disability progression. For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with ...

Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse ...

long considered the best way to monitor MS disease progression, may not be the most accurate predictor of how an individual’s disease will progress. With the advent of new, iron-sensitive neuroimaging ...

These lesions occur in MS due to damage to myelin, the protective area around nerve cells. Image by Marvin 101 on Wikimedia Commons A new study by UC San Francisco has found that menopause revs up the ...